Overweight and hypertension : a 2-way street?

Cross-sectionally, higher weight is associated with higher blood pressure levels; prospectively, baseline weight and weight gain predict higher blood pressure. The loss of weight is frequently associated with a decrease in blood pressure. These findings suggest that weight gain may pathophysiologically contribute to blood pressure elevation. In this review, we present data to indicate that the reverse is also true; persons of equal weight who had higher initial blood pressures gain more weight in the future. We also propose a plausible hypothesis to explain this reverse relationship. Both the blood pressure elevation and the gain of weight may reflect a primary increase in sympathetic tone. It is well known that in a milieu of increased sympathetic tone, the beta-adrenergic responsiveness decreases. Sympathetic overactivity and decreased cardiovascular beta-adrenergic responsiveness have been described in hypertension. beta-Adrenergic receptors mediate increases in energy expenditure. If these metabolic receptors were downregulated in hypertension, the ability of hypertensive patients to dissipate calories would decrease and they would gain more weight. The possible relationship of decreased beta-adrenergic responsiveness to weight in hypertension can be experimentally tested. Such research may contribute to an explanation of why patients with hypertension can rarely lose weight. An understanding of this pathophysiological relationship may open new avenues for therapeutic interventions.

[1]  J. Cutler,et al.  Obesity and hypertension: epidemiological and clinical issues. , 1987, European heart journal.

[2]  O. Bertel,et al.  Decreased Beta‐Adrenoreceptor Responsiveness as Related to Age, Blood Pressure, and Plasma Catecholamines in Patients with Essential Hypertension , 1980, Hypertension.

[3]  B. Saltin,et al.  The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density. , 1992, Blood pressure.

[4]  J. Stamler,et al.  Weight and blood pressure. Findings in hypertension screening of 1 million Americans. , 1978, JAMA.

[5]  S. Kjeldsen,et al.  Sympathetic Nervous System Involvement in Essential Hypertension: Increased Platelet Noradrenaline Coincides with Decreased β-Adrenoreceptor Responsiveness , 1994 .

[6]  J. Stamler,et al.  Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). , 1995, Preventive medicine.

[7]  V. Campese,et al.  Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. , 1982, Kidney international.

[8]  S. Julius,et al.  The hemodynamic link between insulin resistance and hypertension. , 1991, Journal of hypertension.

[9]  P. Korner,et al.  Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension. , 1981, Clinical science.

[10]  R. Schwartz,et al.  Reduced metabolic rate during beta-adrenergic blockade in humans. , 1991, Metabolism: clinical and experimental.

[11]  J. Bülow,et al.  Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue. , 1992, The American journal of physiology.

[12]  M. S. Leaning,et al.  Analytical Review , 2020, 1789.

[13]  E. Ravussin,et al.  Skeletal muscle metabolism is a major determinant of resting energy expenditure. , 1990, The Journal of clinical investigation.

[14]  R. Schwartz,et al.  Reduced metabolic rate during β-adrenergic blockade in humans☆ , 1991 .

[15]  S. Silberstein,et al.  Sympathetic nervous system activity and the thermic effect of feeding in man. , 1987, International journal of obesity.

[16]  L. Landsberg,et al.  Sympathoadrenal system and regulation of thermogenesis. , 1984, The American journal of physiology.

[17]  G Mancia,et al.  Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.

[18]  W. Kannel,et al.  The relation of adiposity to blood pressure and development of hypertension. The Framingham study. , 1967, Annals of internal medicine.

[19]  G. Paolisso,et al.  Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat. , 1997, The American journal of physiology.

[20]  M. White,et al.  Age, hypertension, and cardiac responses to β‐agonist in humans , 1998 .

[21]  C. Stein,et al.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. , 1995, The Journal of clinical investigation.

[22]  L. Landsberg Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. , 1986, The Quarterly journal of medicine.

[23]  J Miura,et al.  [Obesity and hypertension]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.

[24]  A. Hill,et al.  Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. , 1987, International journal of obesity.

[25]  M. Caron,et al.  Turning off the signal: desensitization of β‐adrenergic receptor function , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  R. Feldman,et al.  Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. , 1987, The Journal of clinical investigation.

[27]  R. Townsend,et al.  Lipolytic sensitivity and response to fasting in normotensive and hypertensive obese humans. , 1997, Metabolism: clinical and experimental.

[28]  S. Toubro,et al.  Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[29]  S. Nesbitt,et al.  Parental hyperdynamic circulation predicts insulin resistance in offspring: The Tecumseh Offspring Study. , 1999, Hypertension.

[30]  V. Stevens,et al.  Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[31]  E. Ravussin,et al.  Thermic effect of glucose in man. Obligatory and facultative thermogenesis. , 1984, The Journal of clinical investigation.

[32]  D. Goldstein,et al.  Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.

[33]  J. Giacobino,et al.  Beta 3-adrenoceptor: an update. , 1995, European journal of endocrinology.

[34]  P. Vokonas,et al.  Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. , 1990, Annals of epidemiology.

[35]  S. Welle,et al.  Thermic effect of feeding in man: increased plasma norepinephrine levels following glucose but not protein or fat consumption. , 1981, Metabolism: clinical and experimental.

[36]  M. Blaufox,et al.  The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. , 1992, Archives of internal medicine.

[37]  P. Nestel,et al.  Noradrenaline turnover during under- and over-eating in normal weight subjects. , 1982, Metabolism: clinical and experimental.

[38]  S. Julius,et al.  Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension , 1971, Circulation.

[39]  R. DeFronzo,et al.  Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. , 1984, The Journal of clinical investigation.

[40]  W. Saris,et al.  Adrenoceptor subtypes mediating catecholamine-induced thermogenesis in man. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[41]  E A Anderson,et al.  Elevated Sympathetic Nerve Activity in Borderline Hypertensive Humans Evidence From Direct Intraneural Recordings , 1989, Hypertension.

[42]  M. Condorelli,et al.  Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. , 1983, Hypertension.

[43]  Tataranni Pa From physiology to neuroendocrinology: a reappraisal of risk factors of body weight gain in humans. , 1998 .

[44]  N. Schork,et al.  Hyperkinetic borderline hypertension in Tecumseh, Michigan , 1991, Journal of hypertension.

[45]  S. Julius,et al.  Altered Cardiac Responsiveness and Regulation in the Normal Cardiac Output Type of Borderline Hypertension , 1975, Circulation research.

[46]  C. Furberg,et al.  Long term propranolol treatment and changes in body weight after myocardial infarction. , 1990, BMJ.

[47]  V. Somers,et al.  An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. , 1999, Journal of hypertension.

[48]  E. Ravussin,et al.  A brief overview of human energy metabolism and its relationship to essential obesity. , 1992, The American journal of clinical nutrition.

[49]  M. Lohse,et al.  Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.

[50]  M. Goran,et al.  Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. , 1995, Journal of applied physiology.

[51]  J. Bülow,et al.  Contribution of skeletal muscle and adipose tissue to adrenaline-induced thermogenesis in man. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[52]  G. Jennings,et al.  Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. , 1997, Clinical and experimental hypertension.

[53]  A. Astrup,et al.  Facultative thermogenesis induced by carbohydrate: a skeletal muscle component mediated by epinephrine. , 1986, The American journal of physiology.

[54]  P. Vollenweider,et al.  Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.

[55]  A. Astrup,et al.  Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. , 1985, The American journal of physiology.

[56]  L. Landsberg,et al.  Stimulation of the sympathetic nervous system during sucrose feeding , 1977, Nature.

[57]  S. Julius,et al.  Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. , 1994, Journal of hypertension.

[58]  L. Sjöström,et al.  Epinephrine sensitivity with respect to metabolic rate and other variables in women. , 1983, The American journal of physiology.

[59]  E Casiglia,et al.  Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. , 1997, Hypertension.

[60]  N. Schork,et al.  The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. , 1990, JAMA.

[61]  L. Landsberg,et al.  Suppression of sympathetic nervous system during fasting. , 1997, Obesity research.

[62]  J. Tuomilehto,et al.  Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.

[63]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[64]  I. Macdonald,et al.  Catecholamines and the control of metabolism in man. , 1985, Clinical science.

[65]  S Cerutti,et al.  Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. , 1988, Journal of hypertension.

[66]  F. Messerli,et al.  Plasma Cyclic Adenosine 3':5' ‐Monophosphate Response to Isoproterenol and Glucagon in Hyperkinetic Borderline (Labile) Hypertension , 1976, Circulation research.

[67]  Rudolph L. Leibel,et al.  Medical progress: Obesity. , 1997 .

[68]  T. Kotchen,et al.  Peripheral beta-receptor responsiveness in patients with essential hypertension. , 1979, Archives of internal medicine.

[69]  G. Jennings,et al.  Biochemical evidence of sympathetic hyperactivity in human hypertension. , 1991, Hypertension.

[70]  R. Leibel,et al.  Autonomic nervous system activity in weight gain and weight loss. , 1995, The American journal of physiology.

[71]  R. Feldman Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. , 1990, The Journal of clinical investigation.